SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Cooper Joseph Patrick (Last) (First) (Middle) 8125 N. HAYDEN ROAD (Street) SCOTTSDALE AZ 85258 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/10/2006	3. Issuer Name and Ticker or Trading Symbol MEDICIS PHARMACEUTICAL CORP [ MRX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP,Corp & Product Development	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	31,200(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option(2)	07/16/2005	07/16/2014	Common Stock	63,000	$38.45	D
Employee Stock Option(3)	03/01/2007	03/01/2013	Common Stock	63,000	$23.01	D
Employee Stock Option(4)	07/31/2004	07/31/2013	Common Stock	63,000	$29.2	D
Employee Stock Option(5)	07/21/2006	07/21/2015	Common Stock	28,500	$32.41	D

Explanation of Responses:

1. Includes 4,000 shares received from a restricted stock lapse that occurred on 3/1/06. Includes 16,000 shares from Restricted Stock grant dated 3/1/03- Remaining vesting of 30% on 3/1/07 and 50% on 3/1/08. Includes 5,700 shares of Restricted Stock Grant vesting over 5 years on grant date beginning 7/21/2006- 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5. Includes 5,500 shares Restricted Stock Grant Vesting over 5 years on grant date beginning 2/7/2007- 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.

2. NQ Employee Stock Option vesting over 5 years on grant date beginning 7/16/2005. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.

3. NQ Employee Stock Option grant dated 3/1/03. Vesting 50% on 3/1/07 and 50% on 3/1/08.

4. NQ Employee Stock Option vesting over 5 years on grant date beginning 7/31/2004. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.

5. NQ Employee Stock Option vesting over 5 years on grant date beginning 7/21/2006. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.

	Joseph Cooper	07/19/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.